Khalid Islam
chairman
management
Oxthera
Sweden
Biography
Dr. Khalid Islam has over 29 years of experience in the pharmaceutical and biotechnology industry and is the Managing Director of Life Sciences Management GmbH. Previously, Dr. Islam served as chairman and CEO of Gentium S.p.A. . Under his leadership Gentium completed a $1billion in a cash merger with Jazz Pharmaceuticals, plc. From 1999-2008, he was president and CEO of Arpida AG, a SWX-listed company and raised $300M in the IPO and follow-ons. Dr. Islam is currently the chairman of the Board of Directors of Fennec Pharma and Minoryx Therapeutics and is a member of the Board of Directors of Karolinska Development.
Research Interest
Dr. Islam is a graduate of Chelsea College and received his PhD from Imperial College, University of London. He holds several patents and has published over 80 articles in leading journals.
